-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Maravai Lifesciences Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2025.
- Maravai Lifesciences Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $6.79M, a 50.7% decline year-over-year.
- Maravai Lifesciences Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $40.8M, a 9.66% decline year-over-year.
- Maravai Lifesciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $49.4M, a 42.9% increase from 2023.
- Maravai Lifesciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $34.6M, a 85.3% increase from 2022.
- Maravai Lifesciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18.7M, a 78.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)